Table 1 Demographic and clinical characteristics of the eligible patients
Variables | Eligible patients (n = 5055) | |
|---|---|---|
Gender (n, %) | Male | 2230 (44.1) |
Female | 2825 (55.9) | |
Onset age (n, %) | Infancy | 1357 (26.8) |
Neonatal | 1257 (24.9) | |
Childhood | 1093 (21.6) | |
Adult | 888 (17.6) | |
Antenatal | 269 (5.3) | |
Adolescent | 183 (3.6) | |
Elderly | 4 (0.1) | |
Unknown | 4 (0.1) | |
Symptoms (n, %) | Nervous system | 2280 (45.1) |
Musculoskeletal system | 1722 (34.1) | |
Head or neck | 1231 (24.4) | |
Cardiovascular system | 1125 (22.3) | |
Eye | 1057 (20.9) | |
Metabolism/homeostasis | 847 (16.8) | |
Integument | 834 (16.5) | |
Limbs | 719 (14.2) | |
Genitourinary system | 714 (14.1) | |
Growth | 794 (15.7) | |
Ear | 637 (12.6) | |
Digestive system | 591 (11.7) | |
Blood and blood-forming tissues | 408 (8.1) | |
Endocrine system | 384 (7.6) | |
Immune system | 385 (7.6) | |
Respiratory system | 208 (4.1) | |
Neoplasm | 148 (2.9) | |
Prenatal development or birth | 103 (2.0) | |
Constitutional symptom | 118 (2.3) | |
Breast | 35 (0.7) | |
Cellular | 45 (0.9) | |
Voice | 25 (0.5) | |
Thoracic cavity | 1 (0.0) | |